Dr. Saurav Chandra received his MS as well as PhD in Biomedical Engineering from the University of Florida in 2012. His thesis project involved developing high resolution diffusion MRI techniques to investigate early structural changes in the retina due to diabetic retinopathy. Upon graduation, he joined Novartis Institutes for Biomedical Research at Cambridge, MA where his work focused on preclinical MRI applications in the drug discovery process. Later, Dr. Chandra returned to the world of Ophthalmology as a post-doctoral fellow at the University of Texas Health Science Center at San Antonio (UTHSCSA). His primary research focuses on developing preclinical MRI applications such as blood flow imaging in the eye and diffusion weighted imaging of the optic nerve. These techniques are applied to various ocular diseases such as glaucoma, optic nerve pathology and diabetic retinopathy. This line of research over the years has helped Dr. Chandra acquire a vast knowledge of clinical ophthalmology and various imaging technologies and therapies in this field. Under the guidance of Dr. Timothy Duong, a leading expert in the field of Ophthalmology (particularly Ocular MRI), he has successfully published multiple first author articles in various high impact journals within a short span of time.
Imaging technologies in Opthalmology, some of which may include MRI; fMRI; OCT; ERG; Adaptive Optics; Flicker Perimetry; Fundus Autofluorescence (FAF) Imaging; Fluorescein Angiography; Focal/Multifocal ERG etc.